0001835022-21-000001.txt : 20210105 0001835022-21-000001.hdr.sgml : 20210105 20210104185904 ACCESSION NUMBER: 0001835022-21-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20210105 DATE AS OF CHANGE: 20210104 EFFECTIVENESS DATE: 20210105 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Coya Therapeutics, Inc. CENTRAL INDEX KEY: 0001835022 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-385191 FILM NUMBER: 21503341 BUSINESS ADDRESS: STREET 1: 12645 MEMORIAL DR., SUITE F1 #305 CITY: HOUSTON STATE: TX ZIP: 77024 BUSINESS PHONE: 650.739.3939 MAIL ADDRESS: STREET 1: 12645 MEMORIAL DR., SUITE F1 #305 CITY: HOUSTON STATE: TX ZIP: 77024 D 1 primary_doc.xml X0708 D LIVE 0001835022 Coya Therapeutics, Inc. 12645 MEMORIAL DR., SUITE F1 #305 HOUSTON TX TEXAS 77024 1.800.341.9166 DELAWARE None None Corporation true 2020 Howard Berman 12645 Memorial Drive, Suite F1 #305 Houston TX TEXAS 77024 Executive Officer Director Andrea Goldstein 12645 Memorial Drive, Suite F1 #305 Houston TX TEXAS 77024 Executive Officer Director Jani Tuomi c/o Coya Therapeutics, Inc. 12645 Memorial Drive, Suite F1 #305 Houston TX TEXAS 77024 Director Shawn M. Titcomb 900 N. Federal Hwy., Suite 400 Boca Raton FL FLORIDA 33432 Director Biotechnology Decline to Disclose 06b false 2020-12-22 false true true true false 0 Tribal Capital Markets, LLC 38901 Shawn M. Titcomb 2596352 111 South Pineapple Ave., Suite 619 Sarasota FL FLORIDA 34236 IL ILLINOIS TX TEXAS FL FLORIDA MD MARYLAND AZ ARIZONA OH OHIO AL ALABAMA NY NEW YORK MI MICHIGAN NJ NEW JERSEY CA CALIFORNIA KY KENTUCKY true 10000000 10000000 0 false 57 700000 0 In addition to the sales commissions, a warrant to purchase 525,049 shares of the issuer's common stock at a price per share of $1.606 was issued. 0 false Coya Therapeutics, Inc. /s/ Frances Dea Frances Dea Attorney-in-Fact 2021-01-04